Male C57BL/6 mice

↑ Endpoint	Organ	Obs. Time	Dose [%]
↑ Endpoint	Organ	Obs. Time	0	0.002	0.005	0.01	0.02
N	-	-	4	4	4	4	4
serum AH50	-	10 days	26 ± 1.8	25 ± 1.4 (-4%)	24 ± 1.2 (-8%)	19 ± 2.4 (-27%)^a	8 ± 1.4 (-69%)^b,c
serum C3	-	10 days	4.4 ± 2.2	6.9 ± 1.8 (57%)	4.7 ± 0.6 (7%)	4.7 ± 1.2 (7%)^a	2.2 ± 0.2 (-50%)^b,c
serum CH50	-	10 days	33 ± 10	53 ± 20 (61%)	36 ± 4 (9%)	26 ± 6 (-21%)^a	8 ± 1 (-76%)^b,c
spleen: relative weight	spleen	10 days	0.29 ± 0.02	0.26 ± 0.02 (-10%)	0.27 ± 0.04 (-7%)^a	0.22 ± 0.02 (-24%)^b,c	0.17 ± 0.02 (-41%)^b
thymus: relative weight	thymus	10 days	0.19 ± 0.006	0.18 ± 0 (-5%)	0.16 ± 0.02 (-16%)^a	0.09 ± 0.002 (-53%)^b,c	0.03 ± 0.006 (-84%)^b
^a NOEL (No observed effect level) ^b Significantly different from control (p < 0.05) ^c LOEL (Lowest observed effect level)

Endpoints which have no dose-response data extracted.